$HSCSW News
Last published 3w ago
- 3w agoHSCSHSCSWHeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude MiningGlobeNewswireDefinitive proxy statement filed with the SEC, marking an important milestone toward completion of the proposed transactionHeartSciences Board of Directors unanimously recommends shareholders vote FOR the
- 1mo agoHSCSHSCSWHeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business UpdateGlobeNewswireProposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026 Commercial effort concentrated on
- 2mo agoHSCSHSCSWFortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger ConsiderationGlobeNewswireFortitude purchased approximately $1,000,000 of HeartSciences’ shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase dateThe exchange ratio under the merger agreement with
- 3mo agoHSCSHSCSWHeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial ResultsGlobeNewswireCompany believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders Fiscal 2026 saw the full commercial launch of the MyoVista
- 3mo agoHSCSHSCSWHeartSciences Files Its Fiscal 2026 Annual Report on Form 10-KGlobeNewswireSouthlake, TX, July 23, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on
- 5mo agoHSCSHSCSWEuropean Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted PatentsGlobeNewswireSouthlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography
- 5mo agoHSCSHSCSWHeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared AlgorithmGlobeNewswireSouthlake, TX, June 02, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography
- 5mo agoHSCSHSCSWHeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health NetworkGlobeNewswireSouthlake, TX, May 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography
- 6mo agoHSCSHSCSWHeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™GlobeNewswireSouthlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography
- 7mo agoHSCSHSCSWHeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders MeetingGlobeNewswireSouthlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company") a healthcare information technology ("HIT") company focused on advancing electrocardiography
- 7mo agoHSCSHSCSWHeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System CategoryGlobeNewswireSouthlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing
- 7mo agoHSCSHSCSWHeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor MeetingsGlobeNewswireSouthlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing
- 8mo agoHSCSHSCSWHeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireSouthlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing
- 9mo agoHSCSHSCSWUniversity of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference CenterGlobeNewswireSouthlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS; HSCSW), HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing electrocardiography
- 9mo agoHSCSHSCSWCibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent HospitalsGlobeNewswireSouthlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing
- 11mo agoHSCSHSCSWHeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireSouthlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG"
- 11mo agoHSCSHSCSWHeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ DeviceGlobeNewswireSouthlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use of ECG/EKGs through
- 11mo agoHSCSHSCSWHeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1GlobeNewswireSouthlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use of ECG/EKGs through
- 1y agoHSCSHSCSWHeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial ResultsGlobeNewswireSouthlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Announces Conference Participation and Investor WebinarGlobeNewswireSouthlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Provides Business Update and Reports Fiscal 2025 Financial ResultsGlobeNewswireSouthlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic StenosisGlobeNewswireSouthlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI") powered medical technology company focused on advancing
- 1y agoHSCSHSCSWFoundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP ValueGlobeNewswireSouthlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI") powered medical technology company focused on transforming
- 1y agoHSCSHSCSWHeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial MilestoneGlobeNewswireSouthlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming
- 1y agoHSCSHSCSWHeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025GlobeNewswireSouthlake, TX, May 20, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on
- 1y agoHSCSHSCSWHeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew SimpsonGlobeNewswireSouthlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on
- 1y agoHSCSHSCSWHeartSciences Adds Prominent Key Advisors to its Scientific Advisory BoardGlobeNewswireSouthlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on
- 1y agoHSCSHSCSWHeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter ProgramGlobeNewswireSouthlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial ResultsGlobeNewswireSouthlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Inc. Engages Integrous Communications to Enhance Investor CommunicationsGlobeNewswireSouthlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company
- 1y agoHSCSHSCSWHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial ResultsGlobeNewswireSouthlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused
- 1y agoHSCSHSCSWHeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid ReimbursementGlobeNewswireSouthlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences to Participate in the 2024 Maxim Healthcare Virtual SummitGlobeNewswireSouthlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial ResultsGlobeNewswireSouthlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA SubmissionGlobeNewswireSouthlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Provides Business Update and Reports Fiscal 2024 Financial ResultsGlobeNewswireSouthlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWInnovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway EfficiencyGlobeNewswireSouthlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform HealthcareGlobeNewswireSouthlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart DysfunctionGlobeNewswireSouthlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Regains Compliance with Nasdaq Listing RequirementsGlobeNewswireSouthlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Announces Further Internationalization of its AI-ECG Patent PortfolioGlobeNewswireSouthlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECGGlobeNewswireSouthlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical
- 2y agoHSCSHSCSWHeartSciences to Present at the LD Micro Invitational XIV ConferenceGlobeNewswireSouthlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsGlobeNewswireSouthlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical
- 2y agoHSCSHSCSWHeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsGlobeNewswireSouthlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesGlobeNewswireSouthlake, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical
- 2y agoHSCSHSCSWHeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet TechnologyGlobeNewswireSouthlake, TX, March 06, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology
- 2y agoHSCSHSCSWHeartSciences Adds Key Advisor to its Scientific Advisory BoardGlobeNewswireSouthlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences Expands its Scientific Advisory BoardGlobeNewswireSouthlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered
- 2y agoHSCSHSCSWHeartSciences Appoints New Scientific Advisory Board MemberGlobeNewswireSouthlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered